<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7652606\results\search\disease\results.xml">
  <result pre="Vietnam and China, and it is well known for treating" exact="influenza" post="and some digestive conditions according to traditional medicine [1â€&quot;5]."/>
  <result pre="scaffold, as well as anticancer activities against various types of" exact="cancer" post="cells [38]. Although there has been a modest number"/>
  <result pre="(38), the major chalcone isolated from S. nervosum, on different" exact="cancer" post="cell lines. The half-maximal inhibitory concentration (IC50) and respective"/>
  <result pre="cancer cell lines. The half-maximal inhibitory concentration (IC50) and respective" exact="cancer" post="cell lines are summarized in Table 2. In general,"/>
  <result pre="In general, DMC was found to be active against many" exact="cancer" post="cell lines with different magnitude of cytotoxicity. The chalcone"/>
  <result pre="2.3â€‰Â±â€‰0.44â€‰Î¼M. DMC was also very active against a variety of" exact="cancer" post="cell lines with IC50 ranging from 8 to 15â€‰Î¼M,"/>
  <result pre="15â€‰Î¼M, such as HepG2, ASK, P-388, and PANC-1. For other" exact="cancer" post="cell lines, DMC only showed moderate activities (IC50 30â€&quot;85â€‰Î¼M)."/>
  <result pre="among reported data on cytotoxicity of DMC in the same" exact="cancer" post="cells from independent pharmacological studies [25, 38]. The variation"/>
  <result pre="drugs, such as 5-fluorouracil (5-FU), Taxol, and doxorubicin against drug-resistant" exact="cancer" post="cells resulted in enhanced drug sensitivity in cancer cells."/>
  <result pre="against drug-resistant cancer cells resulted in enhanced drug sensitivity in" exact="cancer" post="cells. Specifically, Qian et al. [15] investigated the reversal"/>
  <result pre="same group reported the reversal effects of DMC in drug-resistant" exact="cancer" post="cells in the human hepatocellular tumor xenograft model. A"/>
  <result pre="[16]. The underlying mechanism of DMC against the multidrug-resistant BEL-7402/5-FU" exact="hepatocellular carcinoma" post="cells was determined to be through the mitochondria-dependent apoptotic"/>
  <result pre="all DMC synthetic analogues showed strong antiproliferative activities on different" exact="cancer" post="cell lines (IC50 values from 1.3â€‰Â±â€‰0.16 to 24.7â€‰Â±â€‰3.94â€‰Î¼M), and"/>
  <result pre="they also displayed synergistic effects with Taxol against a multidrug-resistant" exact="cancer" post="cell line (Hela/Tax). The most promising synergistic effects were"/>
  <result pre="even have synergistic effects with drugs when treated in resistant" exact="cancer" post="cells. Further studies, especially in animal models, should be"/>
  <result pre="should be done to clarify the application of DMC in" exact="cancer" post="treatment. 6.1.3. Chemopreventive Effects Treatment of aqueous extract of"/>
  <result pre="45]. Other studies of anticancer effects of DMC on different" exact="cancer" post="cell lines (K562 (leukemia cells) or PANC-1 (pancreatic cancer"/>
  <result pre="different cancer cell lines (K562 (leukemia cells) or PANC-1 (pancreatic" exact="cancer" post="cells)) also indicated that the chalcone could lower Bcl-2/Bax"/>
  <result pre="leaves were also found to inhibit the enzymatic activity of" exact="influenza" post="neuraminidase. Noticeably, besides the C-methylated flavonoids, glycosides (45 and"/>
  <result pre="antiviral, and antidiabetic activities. DMC showed potent cytotoxicity against various" exact="cancer" post="cell lines via different mechanisms of action. In addition,"/>
  <result pre="addition, DMC was found to reverse the drug-resistant abilities of" exact="cancer" post="cells and significantly improve the anticancer effects of well-known"/>
  <result pre="showed very promising results in in vitro setups, especially against" exact="influenza" post="viruses (H1N1 and H9N2), which supported the traditional use"/>
  <result pre="flavonoids from Cleistocalyx operculatus and their inhibitory effects on novel" exact="influenza" post="A (H1N1) neuraminidaseJournal of Natural Products201073101636164210.1021/np100275320886838 9SongJ.-G.SuJ.-C.SongQ.-Y.et al.Cleistocaltones A"/>
  <result pre="L.WeiD. Z.LuY. H.YangS. L.In vitro and in vivo reversal of" exact="cancer" post="cell multidrug resistance by 2â€²,4â€²-dihydroxy-6â€²-methoxy-3â€²,5â€²-dimethylchalconeJournal of Chemotherapy200517330931410.1179/joc.2005.17.3.30916038525 16HuangH. Y.NiuJ."/>
  <result pre="H.Reversal effect of 2â€²,4â€²-dihydroxy-6â€²-methoxy-3â€²,5â€²-dimethylchalcone on multi-drug resistance in resistant human" exact="hepatocellular carcinoma" post="cell line BEL-7402/5-FUPhytomedicine201118121086109210.1016/j.phymed.2011.04.00121596545 18TayaS.PunvittayagulC.InbootW.FukushimaS.WongpoomchaiR.Cleistocalyx nervosum extract ameliorates chemical-induced oxidative"/>
  <result pre="H.QianF.In vitro anti-tumor activity of 2â€²,4â€²-dihydroxy-6â€²-methoxy-3â€²,5â€²-dimethylchalcone against six established human" exact="cancer" post="cell linesPharmacological Research200450550551010.1016/j.phrs.2004.05.00415458771 24TranP. T.NgoT. Q.-M.LeeS.et al.Identification of anti-osteoclastogenic"/>
  <result pre="effects of 2â€²,4â€²-dihydroxy-6â€²-methoxy-3â€²,5â€²- dimethylchalcone from Cleistocalyx operculatus buds on human" exact="pancreatic cancer" post="cell linesMolecules20192414253810.3390/molecules24142538 40ShiJ.-F.WuP.JiangZ.-H.WeiX.-Y.Synthesis and tumor cell growth inhibitory activity"/>
  <result pre="of 2â€²,4â€²-dihydroxy-6â€²-methoxy-3â€²,5â€²- dimethylchalcone from Cleistocalyx operculatus buds on human pancreatic" exact="cancer" post="cell linesMolecules20192414253810.3390/molecules24142538 40ShiJ.-F.WuP.JiangZ.-H.WeiX.-Y.Synthesis and tumor cell growth inhibitory activity"/>
  <result pre="46YeC. L.QianF.WeiD. Z.LuY. H.LiuJ. W.Induction of apoptosis in K562 human" exact="leukemia" post="cells by 2â€²,4â€²-dihydroxy-6â€²-methoxy-3â€²,5â€²-dimethylchalconeLeukemia Research200529888789210.1016/j.leukres.2005.01.00615978939 47HuY. C.LuoY. D.LiL.JoshiM. K.LuY. H.In"/>
  <result pre="Leaves [22] Table 2 Cytotoxicity (IC50) of DMC against different" exact="cancer" post="cell lines. Cancer cell line Description IC50 (Î¼m) Reference"/>
  <result pre="Cancer cell line Description IC50 (Î¼m) Reference P-388 Mouse lymphoid" exact="neoplasm" post="10.31 [25] KB Human epidermoid carcinoma in the mouth"/>
  <result pre="Human epidermoid carcinoma in the mouth 15.90 â€&quot; MCF-7 Human" exact="breast cancer" post="14.51 â€&quot; A549 Human lung cancer 13.04 â€&quot; ASK"/>
  <result pre="epidermoid carcinoma in the mouth 15.90 â€&quot; MCF-7 Human breast" exact="cancer" post="14.51 â€&quot; A549 Human lung cancer 13.04 â€&quot; ASK"/>
  <result pre="15.90 â€&quot; MCF-7 Human breast cancer 14.51 â€&quot; A549 Human" exact="lung cancer" post="13.04 â€&quot; ASK Rat glioma 9.00 â€&quot; PANC-1 Human"/>
  <result pre="â€&quot; MCF-7 Human breast cancer 14.51 â€&quot; A549 Human lung" exact="cancer" post="13.04 â€&quot; ASK Rat glioma 9.00 â€&quot; PANC-1 Human"/>
  <result pre="14.51 â€&quot; A549 Human lung cancer 13.04 â€&quot; ASK Rat" exact="glioma" post="9.00 â€&quot; PANC-1 Human pancreas 10.5â€‰Â±â€‰0.8 [39] MIA-PACA2 Human"/>
  <result pre="10.5â€‰Â±â€‰0.8 [39] MIA-PACA2 Human pancreatic carcinoma 12.2â€‰Â±â€‰0.9 â€&quot; SMMC-7721 Liver" exact="cancer" post="32.3â€‰Â±â€‰1.13 [23] 8898 Pancreas cancer 37.2â€‰Â±â€‰2.15 â€&quot; SPC-A-1 Lung"/>
  <result pre="carcinoma 12.2â€‰Â±â€‰0.9 â€&quot; SMMC-7721 Liver cancer 32.3â€‰Â±â€‰1.13 [23] 8898 Pancreas" exact="cancer" post="37.2â€‰Â±â€‰2.15 â€&quot; SPC-A-1 Lung cancer 84.6â€‰Â±â€‰4.36 â€&quot; HeLa Tumor"/>
  <result pre="cancer 32.3â€‰Â±â€‰1.13 [23] 8898 Pancreas cancer 37.2â€‰Â±â€‰2.15 â€&quot; SPC-A-1 Lung" exact="cancer" post="84.6â€‰Â±â€‰4.36 â€&quot; HeLa Tumor of cervix uteri 37.7â€‰Â±â€‰1.64 â€&quot;"/>
  <result pre="HeLa Tumor of cervix uteri 37.7â€‰Â±â€‰1.64 â€&quot; 95-D High metastatic" exact="lung carcinoma" post="84.8â€‰Â±â€‰4.71 â€&quot; GBC-SD Gall bladder carcinoma 81.3â€‰Â±â€‰2.75 â€&quot; A549"/>
  <result pre="84.8â€‰Â±â€‰4.71 â€&quot; GBC-SD Gall bladder carcinoma 81.3â€‰Â±â€‰2.75 â€&quot; A549 Human" exact="lung cancer" post="2.3â€‰Â±â€‰0.44 [38] HepG2 Human liver cancer 8.3â€‰Â±â€‰0.22 â€&quot; MCF-7"/>
  <result pre="â€&quot; GBC-SD Gall bladder carcinoma 81.3â€‰Â±â€‰2.75 â€&quot; A549 Human lung" exact="cancer" post="2.3â€‰Â±â€‰0.44 [38] HepG2 Human liver cancer 8.3â€‰Â±â€‰0.22 â€&quot; MCF-7"/>
  <result pre="81.3â€‰Â±â€‰2.75 â€&quot; A549 Human lung cancer 2.3â€‰Â±â€‰0.44 [38] HepG2 Human" exact="liver cancer" post="8.3â€‰Â±â€‰0.22 â€&quot; MCF-7 Human breast cancer 15.1â€‰Â±â€‰0.72 â€&quot; HeLa"/>
  <result pre="â€&quot; A549 Human lung cancer 2.3â€‰Â±â€‰0.44 [38] HepG2 Human liver" exact="cancer" post="8.3â€‰Â±â€‰0.22 â€&quot; MCF-7 Human breast cancer 15.1â€‰Â±â€‰0.72 â€&quot; HeLa"/>
  <result pre="2.3â€‰Â±â€‰0.44 [38] HepG2 Human liver cancer 8.3â€‰Â±â€‰0.22 â€&quot; MCF-7 Human" exact="breast cancer" post="15.1â€‰Â±â€‰0.72 â€&quot; HeLa Tumor of cervix uteri 11.8â€‰Â±â€‰0.42 â€&quot;"/>
  <result pre="[38] HepG2 Human liver cancer 8.3â€‰Â±â€‰0.22 â€&quot; MCF-7 Human breast" exact="cancer" post="15.1â€‰Â±â€‰0.72 â€&quot; HeLa Tumor of cervix uteri 11.8â€‰Â±â€‰0.42 â€&quot;"/>
 </snippets>
</snippetsTree>
